Craft

Allarity Therapeutics

Stock Price

$1.5

2024-10-29

Market Capitalization

$2.2 M

2024-10-29

Allarity Therapeutics Summary

Company Summary

Overview
Allarity Therapeutics (formerly known as Oncology Venture) is a drug development company dedicated to unlocking the potential of oncology products and rescue failed drugs. Its method promotes the efficacy of the drugs, increases the response rate in cancer patients, reduces timelines, and improves success rates in oncology drug development.
Type
Public
Status
Active
Founded
2004
HQ
Boston, MA, US | view all locations
Website
https://allarity.com/
Cybersecurity rating
Sectors

Key People

  • Joseph Vazzano

    Joseph Vazzano, Independent Board Member

  • Steen Knudsen

    Steen Knudsen, Founder, Chief Scientific Officer

  • Thomas Jensen

    Thomas Jensen, Founder & Chief Executive Officer, Board Member

  • Jerry McLaughlin

    Jerry McLaughlin, Chairman, Independent Board Member

    LocationsView all

    2 locations detected

    • Boston, MA HQ

      United States

      24 School Street, 2nd Floor

    • Hørsholm

      Denmark

      Venlighedsvej 1

    Allarity Therapeutics Financials

    Summary Financials

    Net income (Q3, 2021)
    (kr20.6M)
    Cash (Q3, 2021)
    kr35.9M
    EBIT (Q3, 2021)
    (kr26.7M)
    Enterprise value
    ($32.8M)

    Footer menu